PIMA537538

SNX6 Monoclonal Antibody (335CT6.4.6), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA537538-Each-of-1 In Stock ₹ 47,481.50

PIMA537538 - Each of 1

₹ 47,481.50

In Stock

Quantity

1

Base Price: ₹ 47,481.50

GST (18%): ₹ 8,546.67

Total Price: ₹ 56,028.17

Antigen

SNX6

Classification

Monoclonal

Conjugate

Unconjugated

Gene

SNX6

Gene Alias

2010006G21Rik; 2610032J07Rik; 2810425K19Rik; AU018928; C85963; MSTP010; SNX6; sorting nexin 6; sorting nexin-6; Sorting nexin-6, N-terminally processed; TFAF2; TRAF4-associated factor 2; tumor necrosis factor receptor-associated factor 4(TRAF4)-associated factor 2

Host Species

Mouse

Purification Method

Protein G

Regulatory Status

RUO

Gene ID (Entrez)

58533

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

Western Blot

Clone

335CT6.4.6

Formulation

PBS with 0.09% sodium azide

Gene Accession No.

Q9UNH7

Gene Symbols

SNX6

Immunogen

SNX6 recombinant protein

Quantity

400 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Thermo Scientific

PIPA5115946

--

Img

Thermo Scientific

PI701823

--

Img

Thermo Scientific

PIPA5111450

--

Img

Thermo Scientific

PIPA5111039

--

Img

Thermo Scientific

PIPA5116288

--

Img

Thermo Scientific

PIPA5111088

--

Img

Thermo Scientific

PIMA531254

--

Img

Thermo Scientific

PIMA531918

--

Description

  • SNX6 interacts with members of the transforming growth factor-beta family of receptor serine-threonine kinases
  • These receptors belong to two classes: type II receptors that bind ligand, and type I receptors that are subsequently recruited to transduce the signal
  • Of the type II receptors, SNX6 was found to interact strongly with ActRIIB and more moderately with wild type and kinase-defective mutants of TbetaRII
  • Of the type I receptors, SNX6 was found to interact only with inactivated TbetaRI
  • SNXs 1-4 also interacted with the transforming growth factor-beta receptor family, showing different receptor preferences
  • Conversely, SNX6 behaved similarly to the other SNX proteins in its interactions with receptor tyrosine kinases
  • Strong heteromeric interactions were also seen among SNX1, -2, -4, and -6, suggesting the formation in vivo of oligomeric complexes
  • These findings are the first evidence for the association of the SNX family of molecules with receptor serine-threonine kinases.